Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- EAS highlights claims regulations across the globe
Companies and regulators from Asia’s food and nutrition sector met in Singapore this week for an informative tour including a seminar, Tuesday June 10 at the Singapore Management University, of nutrition and health claims regulations in Asia, the European Union (EU) and the United States (US).
- EAS highlights claims regulations across the globe
Companies and regulators from Asia’s food and nutrition sector met in Singapore this week for an informative tour including a seminar, Tuesday June 10 at the Singapore Management University, of nutrition and health claims regulations in Asia, the European Union (EU) and the United States (US).
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- Health Canada warns consumers not to use the dietary supplements 6-OXO and 1-AD due to potential serious health risks
Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability. Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada.
- Health Canada warns consumers not to use the dietary supplements 6-OXO and 1-AD due to potential serious health risks
Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability. Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada.
- Health Canada warns consumers not to use the dietary supplements 6-OXO and 1-AD due to potential serious health risks
Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability. Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada.
- Health Canada warns consumers not to use the dietary supplements 6-OXO and 1-AD due to potential serious health risks
Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability. Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada.
- Health Canada warns consumers not to use the dietary supplements 6-OXO and 1-AD due to potential serious health risks
Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability. Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- Native Essence Herb Company Sues FTC
The Federal Trade Commission is being sued over the use of history. A New Mexico herb company says the First Amendment gives it the right to tell customers the historical use of herbs in treating serious diseases. The FTC says this violates its guidelines.
- Native Essence Herb Company Sues FTC
The Federal Trade Commission is being sued over the use of history. A New Mexico herb company says the First Amendment gives it the right to tell customers the historical use of herbs in treating serious diseases. The FTC says this violates its guidelines.
- Seminar looks to global TMHS regulations for ASEAN model
More than 200 people including regulators, academics and industry representatives attended a seminar in Malaysia this month to discuss regional and global developments on Traditional Medicines and Health Supplements (TMHS). Held on June 4, the seminar focused on the harmonisation process for TMHS within the Association of South East Asian Nations (ASEAN), offering representatives the opportunity to learn about other regulatory systems against which the emerging ASEAN model could be benchmarked.
- Seminar looks to global TMHS regulations for ASEAN model
More than 200 people including regulators, academics and industry representatives attended a seminar in Malaysia this month to discuss regional and global developments on Traditional Medicines and Health Supplements (TMHS). Held on June 4, the seminar focused on the harmonisation process for TMHS within the Association of South East Asian Nations (ASEAN), offering representatives the opportunity to learn about other regulatory systems against which the emerging ASEAN model could be benchmarked.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Canada: New Approach to Compendial Reviews
Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications.
- Canada: New Approach to Compendial Reviews
Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications.
- Canada: New Approach to Compendial Reviews
Canada's Natural Health Products Directorate (NHPD) has announced that it has adopted a new approach to the review of compendial Product Licence Applications.
- Stryka Botanics Removes Suit Filed by Certified Natural Laboratories
Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment.
- Stryka Botanics Removes Suit Filed by Certified Natural Laboratories
Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment.
- Stryka Botanics Removes Suit Filed by Certified Natural Laboratories
Stryka Botanics has filed papers with the United States District Court to remove the suit filed by Certified Natural Laboratories, a supplement manufacturer based in Wichita, Kan., alleging that Stryka delivered to them a fake hoodia gordonii shipment.
- NAD Reviews Advertising for ‘Immunasure’
- NAD Reviews Advertising for ‘Immunasure’
- NAD Reviews Advertising for ‘Immunasure’
- NAD Reviews Advertising for ‘Immunasure’
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- Pharmaceutical Consulting Services, LLC offers a new “cost effective” concept in GMP Compliance
Pharmaceutical Consulting Services, LLC is presenting a program in which for a very small monthly fee, PCS conducts quarterly GMP audits, issues audit reports with non-compliance issues clearly indicated, and works with the company’s staff in finding solutions for the non-compliance issues.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
This new approval confirms the integrity and quality of the ingredients Algatechnologies supplies to the dietary supplement and cosmeceuticals industries. It demonstrates Algatechnologies’ commitment to the highest standards of purity, quality and product safety in the industry.
“Our target is to maintain and enhance our leading position in the astaxanthin European market by providing ingredients of the highest quality and purity,” says Efrat Kat, Marketing Manager at Algatechnologies. “We continue to employ strictly controlled manufacturing operations and quality-assurance controls in our facilities. We will constantly increase our distribution network in Europe, as it is a major market for astaxanthin as demonstrated by a growth rate in double-digits over the last few years"
The market size of astaxanthin for human use is currently valued at around (€14-19M) and is forecast to experience significant growth over the next few years, driven by the increase in awareness of its health benefits.
Algatechnologies, a leading supplier of natural astaxanthin produced from Haematococcus pluvialis microalgae is located in Israel's Arava desert -- an optimal location for algae cultivation due to the stable climate conditions in the area and year-round high light intensities. “Producing the microalgae in a closed system and using sunlight as the energy source, allows us to offer an extremely pure product with the highest astaxanthin level. Our products are pesticide-free and allergen-free, and offered at competitive prices," adds Ms. Kat.
The company employs high pressure Super Critical CO2 extraction technology in order to produce 10% astaxanthin in an oleoresin form. This technology does not require the use of organic solvents and therefore the product does not contain any solvents residues.
Algatechnologies holds a world patent for its closed, environmentally protected cultivation system, allowing the production of a pure AstaPure®, astaxanthin product without biological or chemical contamination. Algatechnologies holds ISO 9001/2000, HACCP and GMP (for food) international accreditations.
Astaxanthin is a very potent antioxidant, recognized to be about 500 times more effective than vitamin E and much more powerful than other carotenoids, such as lutein, lycopene and beta-carotene. Astaxanthin supports a number of health conditions including eye health, skin health and health disorders related to the Central Nervous System (CNS).
For further information, please contact:
Ms.Efrat Kat
Marketing Manager
Algatechnologies Ltd.
Phone: +972-8-6356425
Mobile: +972-52-4599528
e-mail: efratk@algatech.com |